These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 25856966)

  • 1. [Evaluation of microalbuminuria and lipid profile among type 2 diabetics].
    Diouf NN; Lo G; Sow-Ndoye A; Djité M; Tine JA; Diatta A
    Rev Med Brux; 2015; 36(1):10-3. PubMed ID: 25856966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levels of inflammatory markers and their correlation with dyslipidemia in diabetics.
    Waheed P; Naveed AK; Farooq F
    J Coll Physicians Surg Pak; 2009 Apr; 19(4):207-10. PubMed ID: 19356332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High level of individual lipid profile and lipid ratio as a predictive marker of poor glycemic control in type-2 diabetes mellitus.
    Artha IMJR; Bhargah A; Dharmawan NK; Pande UW; Triyana KA; Mahariski PA; Yuwono J; Bhargah V; Prabawa IPY; Manuaba IBAP; Rina IK
    Vasc Health Risk Manag; 2019; 15():149-157. PubMed ID: 31239693
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum lipoprotein(a) is not increased in NIDDM patients with microalbuminuria.
    Girelli A; Cimino A; Rocca L; Salvi A; Spandrio S; Valentini U; Guistina A
    Diabetes Care; 1994 May; 17(5):456-7. PubMed ID: 8062619
    [No Abstract]   [Full Text] [Related]  

  • 5. Positive health beliefs are associated with improvement of glycated hemoglobin and lipid profiles in Mexican patients with type 2 diabetes mellitus: a cross-sectional study.
    Muñoz-Torres AV; Medina-Bravo P; Valerio-Pérez BE; Mendoza-Salmeron G; Escobedo-de la Peña J; Velázquez-López L
    BMC Public Health; 2020 May; 20(1):761. PubMed ID: 32448139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin resistance, hypertension and microalbuminuria in patients with type 2 (non-insulin-dependent) diabetes mellitus.
    Groop L; Ekstrand A; Forsblom C; Widén E; Groop PH; Teppo AM; Eriksson J
    Diabetologia; 1993 Jul; 36(7):642-7. PubMed ID: 8359582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid profile abnormalities seen in T2DM patients in primary healthcare in Turkey: a cross-sectional study.
    Ozder A
    Lipids Health Dis; 2014 Dec; 13():183. PubMed ID: 25481115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pattern of dyslipidemia among urban African-Americans with type 2 diabetes.
    Cook CB; Erdman DM; Ryan GJ; Greenlund KJ; Giles WH; Gallina DL; El-Kebbi IM; Ziemer DC; Ernst KL; Dunbar VG; Phillips LS
    Diabetes Care; 2000 Mar; 23(3):319-24. PubMed ID: 10868858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of progression of microalbuminuria in patients with NIDDM.A prospective study.
    Smulders YM; Rakic M; Stehouwer CD; Weijers RN; Slaats EH; Silberbusch J
    Diabetes Care; 1997 Jun; 20(6):999-1005. PubMed ID: 9167114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein(a) and cardiovascular disease in type 2 (non-insulin-dependent) diabetic patients with and without diabetic nephropathy.
    Nielsen FS; Voldsgaard AI; Gall MA; Rossing P; Hommel E; Andersen P; Dyerberg J; Parving HH
    Diabetologia; 1993 May; 36(5):438-44. PubMed ID: 8314449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triglyceride profile in dyslipidaemia of type 2 diabetes mellitus.
    Khan SR; Ayub N; Nawab S; Shamsi TS
    J Coll Physicians Surg Pak; 2008 May; 18(5):270-3. PubMed ID: 18541079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycaemic control and familial factors determine hyperlipidaemia in early childhood diabetes. Oxford Regional Prospective Study of Childhood Diabetes.
    Abraha A; Schultz C; Konopelska-Bahu T; James T; Watts A; Stratton IM; Matthews DR; Dunger DB
    Diabet Med; 1999 Jul; 16(7):598-604. PubMed ID: 10445837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of dyslipidemia and the relationship between HbA1C and lipid profile in Moroccan patients with T2DM: a cross-sectional study.
    Alami HE; Haddou I; Benaadi G; Lkhider M; Wakrim L; Allali M; Abidi O; Ghazal H; Idrissi NA; Nabih N; Naamane A; Maaroufi A; Khlil N; Hamdi S
    Pan Afr Med J; 2022; 43():86. PubMed ID: 36605985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [La educación multimedia como apoyo en el manejo de pacientes con diabetes tipo 2. Estudio cuasi experimental].
    Aguila IP; Velázquez-López L; Goycochea-Robles MAV; Angulo-Angulo F; Peña JE
    Cir Cir; 2018; 86(5):404-411. PubMed ID: 30226499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The positive association of branched-chain amino acids and metabolic dyslipidemia in Chinese Han population.
    Yang P; Hu W; Fu Z; Sun L; Zhou Y; Gong Y; Yang T; Zhou H
    Lipids Health Dis; 2016 Jul; 15():120. PubMed ID: 27457614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Albuminuria and 24-h ambulatory blood pressure in normoalbuminuric and microalbuminuric NIDDM patients. A longitudinal study.
    Nielsen S; Schmitz A; Poulsen PL; Hansen KW; Mogensen CE
    Diabetes Care; 1995 Nov; 18(11):1434-41. PubMed ID: 8722066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of microalbuminuria in individuals with IDDM. Pittsburgh Epidemiology of Diabetes Complications Study.
    Coonrod BA; Ellis D; Becker DJ; Bunker CH; Kelsey SF; Lloyd CE; Drash AL; Kuller LH; Orchard TJ
    Diabetes Care; 1993 Oct; 16(10):1376-83. PubMed ID: 8269796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal and retinal microangiopathy after 15 years of follow-up study in a sample of Type 1 diabetes mellitus patients.
    Romero P; Salvat M; Fernández J; Baget M; Martinez I
    J Diabetes Complications; 2007; 21(2):93-100. PubMed ID: 17331857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of troglitazone on microalbuminuria in patients with incipient diabetic nephropathy.
    Imano E; Kanda T; Nakatani Y; Nishida T; Arai K; Motomura M; Kajimoto Y; Yamasaki Y; Hori M
    Diabetes Care; 1998 Dec; 21(12):2135-9. PubMed ID: 9839106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low HDL-cholesterol: a component of the metabolic syndrome only in the presence of fasting hypertriglyceridemia in type 2 diabetic patients.
    Bo S; Cavallo-Perin P; Gentile L; Repetti E; Pagano G
    Diabetes Metab; 2001 Feb; 27(1):31-5. PubMed ID: 11240443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.